|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fowke JH, McLerran DF, Gupta PC, He J, Shu
XO, Ramadas K, Tsugane S, Inoue M, Tamakoshi A, Koh WP, et al:
Associations of body mass index, smoking, and alcohol consumption
with prostate cancer mortality in the Asia Cohort Consortium. Am J
Epidemiol. 182:381–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarker D, Reid AHM, Yap TA and de Bono JS:
Targeting the PI3K/AKT pathway for the treatment of prostate
cancer. Clin Cancer Res. 15:4799–4805. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shukla S: FOXO3a: A potential target in
prostate cancer. Austin J Urol. 12014.
|
|
6
|
Daitoku H, Sakamaki J and Fukamizu A:
Regulation of FoxO transcription factors by acetylation and
protein-protein interactions. Biochim Biophys Acta. 1813:1954–1960.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arrendale A, Kim K, Choi JY, Li W, Geahlen
RL and Borch RF: Synthesis of a phosphoserine mimetic prodrug with
potent 14-3-3 protein inhibitory activity. Chem Biol. 19:764–771.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rinner O, Mueller LN, Hubálek M, Müller M,
Gstaiger M and Aebersold R: An integrated mass spectrometric and
computational framework for the analysis of protein interaction
networks. Nat Biotechnol. 25:345–352. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang W, You RL, Qin WJ, Hai LN, Fang MJ,
Huang GH, Kang RX, Li MH, Qiao YF, Li JW, et al: Anti-tumor
activities of active ingredients in Compound Kushen Injection. Acta
Pharmacol Sin. 36:676–679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Y, Wu Y, Deng L, Chen L, Zhao D, Lv
L, Chen X, Man J, Wang Y, Shan H, et al: The alkaloid matrine of
the root of Sophora flavescens prevents arrhythmogenic effect of
ouabain. Phytomedicine. 21:931–935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo B, Zhang T, Su J, Wang K and Li X:
Oxymatrine targets EGFRp-Tyr845 and inhibits
EGFR-related signaling pathways to suppress the proliferation and
invasion of gastric cancer cells. Cancer Chemother Pharmacol.
75:353–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie M, He G, Wang R, Shi S, Chen J, Ye Y,
Xie L, Yi X and Tang A: Matrine-induced apoptosis of human
nasopharyngeal carcinoma cells via in vitro vascular endothelial
growth factor-A/extracellular signal-regulated kinase1/2 pathway
inactivation. Horm Metab Res. 46:556–560. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L, Wang T, Wen X, Wei Y, Peng X, Li
H and Wei L: Effect of matrine on HeLa cell adhesion and migration.
Eur J Pharmacol. 563:69–76. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and
Su C: Anti-tumor activities of matrine and oxymatrine: Literature
review. Tumour Biol. 35:5111–5119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shukla S, Bhaskaran N, Babcook MA, Fu P,
Maclennan GT and Gupta S: Apigenin inhibits prostate cancer
progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Carcinogenesis. 35:452–460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Q, Lai Y, Wang C, Xu G, He Z, Shang X,
Sun Y, Zhang F, Liu L and Huang H: Matrine inhibits the
proliferation, invasion and migration of castration-resistant
prostate cancer cells through regulation of the NF-κB signaling
pathway. Oncol Rep. 35:375–381. 2016.PubMed/NCBI
|
|
17
|
Wang D, Yang Y, Huang R, Zhang Z and Lin
X: Myostatin activates the ubiquitin-proteasome and
autophagy-lysosome systems contributing to muscle wasting in
chronic kidney disease. Oxid Med Cell Longev. 2015:6849652015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Majumder PK and Sellers WR: Akt-regulated
pathways in prostate cancer. Oncogene. 24:7465–7474. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carnero A: The PKB/AKT pathway in cancer.
Curr Pharm Des. 16:34–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Trotman LC, Alimonti A, Scaglioni PP,
Koutcher JA, Cordon-Cardo C and Pandolfi PP: Identification of a
tumour suppressor network opposing nuclear Akt function. Nature.
441:523–527. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang P, Wang Z, Chong T and Ji Z: Matrine
inhibits proliferation and induces apoptosis of the
androgen-independent prostate cancer cell line PC-3. Mol Med Rep.
5:783–787. 2012.PubMed/NCBI
|
|
22
|
Yaoxian W, Hui Y, Yunyan Z, Yanqin L, Xin
G and Xiaoke W: Emodin induces apoptosis of human cervical cancer
hela cells via intrinsic mitochondrial and extrinsic death receptor
pathway. Cancer Cell Int. 13:712013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nam YJ, Mani K, Ashton AW, Peng CF,
Krishnamurthy B, Hayakawa Y, Lee P, Korsmeyer SJ and Kitsis RN:
Inhibition of both the extrinsic and intrinsic death pathways
through nonhomotypic death-fold interactions. Mol Cell. 15:901–912.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heath-Engel HM and Shore GC: Regulated
targeting of Bax and Bak to intracellular membranes during
apoptosis. Cell Death Differ. 13:1277–1280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Desagher S and Martinou JC: Mitochondria
as the central control point of apoptosis. Trends Cell Biol.
10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takuma K, Baba A and Matsuda T: Astrocyte
apoptosis: Implications for neuroprotection. Prog Neurobiol.
72:111–127. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morimoto M, Nishida T, Honda R and Yasuda
H: Modification of cullin-1 by ubiquitin-like protein Nedd8
enhances the activity of SCFskp2 toward
p27kip1. Biochem Biophys Res Commun. 270:1093–1096.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ray A, James MK, Larochelle S, Fisher RP
and Blain SW: p27Kip1 inhibits cyclin D-cyclin-dependent
kinase 4 by two independent modes. Mol Cell Biol. 29:986–999. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stahl M, Dijkers PF, Kops GJ, Lens SM,
Coffer PJ, Burgering BM and Medema RH: The forkhead transcription
factor FoxO regulates transcription of p27Kip1
and Bim in response to IL-2. J Immunol. 168:5024–5031. 2002.
View Article : Google Scholar : PubMed/NCBI
|
